News and events

Scaling Platform Delivery of Gene Therapies: An Interview with NewBiologix's CEO Igor Fisch

NewBiologix Announces Scientific White Paper on Improving the Manufacturing of Recombinant Adeno-Associated Viruses for Use in Cell & Gene Therapies

NewBiologix Launches U.S. Subsidiary and Welcomes Gene and Cell Therapy Expert David Kelly as Business Development Manager

NewBiologix Launches Xcell™ rAAV Production and Analytics Platform to Improve and Accelerate Gene Therapy Development

ENDPOINTS NEWS: Gene therapies don’t have to cost $4 million: New production platforms reduce development costs and risks

NewBiologix Launches Xcell™ to Accelerate, Optimize, and Scale Gene and Cell Therapy Production

NewBiologix Abstracts Selected for Two Poster Presentations at European Society of Gene & Cell Therapy 2024 Congress

Revolutionizing Gene Therapy with Igor Fisch CEO of NewBiologix

NewBiologix Launches Proprietary HEK293 Cell Line for the Expression of Viral Vectors Used in Gene Therapy